Paxman AB (publ) (STO:PAX)
Sweden · Delayed Price · Currency is SEK 45.00
+0.40 (0.90%)
Mar 24, 2026, 5:29 PM CET
Paxman AB Revenue
In the year 2025, Paxman AB had annual revenue of 323.56M SEK with 22.93% growth. Paxman AB had revenue of 87.05M in the quarter ending December 31, 2025, with 27.06% growth.
Revenue
323.56M
Revenue Growth
+22.93%
P/S Ratio
3.21
Revenue / Employee
2.25M
Employees
144
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 323.56M | 60.36M | 22.93% |
| Dec 31, 2024 | 263.20M | 42.59M | 19.30% |
| Dec 31, 2023 | 220.61M | 63.86M | 40.74% |
| Dec 31, 2022 | 156.75M | 52.04M | 49.70% |
| Dec 31, 2021 | 104.71M | 21.57M | 25.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BICO Group AB | 1.50B |
| CellaVision AB | 748.45M |
| C-Rad AB | 441.90M |
| Mentice AB | 284.59M |
| Bactiguard Holding AB | 225.57M |
| Sedana Medical AB | 200.23M |
| OssDsign AB | 180.16M |
| Senzime AB | 104.02M |